Furthermore, it has also been shown that baseline levels of tumour necrosis factor α (TNFα), interleukin-1β (IL-1β) and IL-6 were elevated in diarrhoea predominant IBS patients (D-IBS) [10]. The gene discussed is IL6; the disease is irritable bowel syndrome.